Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
KUNLUN ENERGY
00135
CN Stock MarketDetailed Quotes
Zhangzhou Pientzehuang Pharmaceutical (600436)
- 127.50
- -0.99-0.77%
Market Closed May 20 15:00 CST
76.92BMarket Cap40.44P/E (TTM)
128.88High126.58Low30.63KlotVolume128.30Open128.49Prev Close390.47MTurnover0.51%Turnover Ratio35.63P/E (Static)603.32MShares217.1752wk High5.06P/B76.92BFloat Cap126.5852wk Low141.34Limit Up603.32MShs Float482.73Historical High115.64Limit Down1.79%Range %-10.55Historical Low3.22Dividend TTM127.49Avg Price13.10KlotAsk2.53%Div Yield TTM100Lot Size15.38KlotBid
Zhangzhou Pientzehuang Pharmaceutical (600436) Balance Sheet
All
YOY
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q9)Sep 30, 2025 | (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Money funds | 40.36%1.96B | -15.60%1.26B | -58.80%1.35B | -80.16%1.77B | -41.29%1.39B | 28.41%1.49B | 24.17%3.27B | 216.82%8.92B | -20.05%2.37B | -53.58%1.16B |
| Notes receivable and accounts receivable | 2.73%942.49M | -6.57%805.57M | 22.38%1.01B | 22.58%1.05B | -3.15%917.46M | -10.97%862.21M | 10.05%825.36M | 12.60%854.5M | 24.41%947.26M | 18.42%968.48M |
| -Notes receivable | -21.29%50.84M | -36.52%52.4M | 25.95%42.73M | 56.13%70.15M | 11.02%64.59M | 45.49%82.55M | -35.92%33.93M | -24.28%44.93M | 17.42%58.18M | -22.79%56.73M |
| -Accounts receivable | 4.55%891.64M | -3.40%753.17M | 22.23%967.35M | 20.72%977.3M | -4.07%852.86M | -14.49%779.66M | 13.54%791.43M | 15.73%809.57M | 24.90%889.08M | 22.48%911.75M |
| Other receivables (including interest and dividends) | -22.11%58.76M | 6.18%67.9M | -1.15%67.49M | -0.46%72.99M | 15.19%75.44M | 12.87%63.95M | -21.95%68.28M | -21.72%73.33M | -34.77%65.49M | -45.45%56.66M |
| -Dividend receivable | ---- | ---- | 4.70%12.56M | -14.71%17.67M | --310.68K | ---- | 0.00%12M | 12.59%20.72M | ---- | ---- |
| -Other receivable | ---- | 6.18%67.9M | ---- | 5.15%55.33M | ---- | 12.87%63.95M | ---- | -30.11%52.61M | ---- | -45.45%56.66M |
| Contractual assets | -77.73%379.64K | -30.66%1.25M | --1.4M | --1.91M | --1.7M | --1.8M | ---- | ---- | ---- | ---- |
| Advance payment | -24.53%215.41M | -6.34%235.45M | -29.37%165.22M | -28.55%192.18M | -19.24%285.41M | -26.16%251.38M | 26.79%233.92M | -29.64%268.96M | 126.52%353.39M | 1.57%340.43M |
| Inventories | 26.94%6.28B | 34.46%6.68B | 34.90%6.16B | 26.09%5.72B | 27.47%4.95B | 47.01%4.97B | 64.13%4.57B | 77.58%4.54B | 43.23%3.88B | 28.57%3.38B |
| Receivable financing | -28.12%56.77M | -20.82%24.08M | -6.57%39.85M | -33.77%38.97M | -36.97%78.98M | -42.36%30.42M | -35.38%42.65M | -42.47%58.85M | 11.98%125.29M | 26.75%52.77M |
| Other current assets | -57.14%1.92B | -56.34%1.6B | -72.09%1.91B | 740.86%3.44B | -47.77%4.48B | -59.93%3.66B | -10.38%6.84B | -94.38%409.62M | 35.50%8.58B | 45.56%9.14B |
| Total current assets | -6.16%11.43B | -5.83%10.67B | -32.47%10.7B | -18.74%12.29B | -25.39%12.18B | -24.97%11.33B | 12.11%15.84B | 8.10%15.13B | 24.24%16.32B | 18.85%15.1B |
| Non Current assets | ||||||||||
| Other equity investment | -1.52%391.4M | 16.49%473.48M | -3.48%423.84M | 22.27%418.92M | 11.57%397.44M | 7.78%406.45M | 8.65%439.13M | -11.54%342.62M | -9.05%356.21M | 0.38%377.1M |
| Other non-current financial assets | -21.16%35.28M | -18.77%42.54M | -3.42%44.52M | -3.36%44.57M | -3.09%44.74M | -14.59%52.37M | 36.80%46.1M | 36.86%46.12M | -7.88%46.17M | 14.41%61.32M |
| Investment real estate | -43.11%9.01M | -42.33%9.37M | 87.23%16.22M | 81.23%16.92M | 32.17%15.84M | 19.08%16.24M | -39.95%8.66M | -38.31%9.34M | -27.09%11.99M | -41.03%13.64M |
| Long-term equity investment | 70.54%877.68M | 106.04%848.09M | 224.11%878.42M | 221.59%559.01M | 164.09%514.64M | 112.67%411.62M | 20.08%271.02M | -21.95%173.83M | -20.99%194.87M | -20.81%193.55M |
| Fixed assets | ---- | -47.08%529.02M | ---- | 281.52%1.22B | ---- | 219.67%999.74M | ---- | 22.36%320.43M | ---- | 19.88%312.74M |
| Fixed assets liquidation | ---- | 140.28%16.8K | ---- | --4.9K | ---- | -84.92%6.99K | ---- | ---- | ---- | 3,641.36%46.37K |
| Constru in process | ---- | 296.52%1.25B | ---- | 86.55%347.95M | ---- | 100.30%314.85M | ---- | 75.84%186.51M | ---- | 158.62%157.19M |
| Productive biological assets | -10.97%8.45M | -18.55%8.39M | -26.13%9.44M | -22.77%9.62M | -22.63%9.49M | -15.76%10.29M | 4.52%12.78M | 3.91%12.45M | 4.09%12.27M | 5.44%12.22M |
| Intangible assets | -1.93%263.85M | -2.06%267.49M | -3.21%267.95M | -4.52%266.48M | -6.71%269.05M | -6.18%273.1M | -10.40%276.83M | -9.78%279.08M | -7.10%288.4M | -8.86%291.09M |
| Long deferred expense | -9.73%28.69M | -10.29%30.54M | 22.36%30.1M | 20.65%30.72M | 15.57%31.78M | 13.52%34.05M | -36.17%24.6M | -42.77%25.46M | -28.73%27.5M | -20.35%29.99M |
| Deferred tax assets | -11.10%118.46M | -25.76%115.43M | -29.76%141M | -29.19%134.72M | -33.87%133.25M | -16.99%155.5M | 6.37%200.72M | 6.46%190.25M | 13.36%201.51M | 11.99%187.31M |
| Usufruct assets | -7.29%157.23M | -17.43%151.27M | 18.33%155.67M | 29.02%164.62M | 24.72%169.59M | 38.30%183.2M | 9.97%131.56M | 1.73%127.59M | 5.89%135.97M | 0.08%132.47M |
| Other non current assets | -0.83%3.18B | -5.55%3.17B | 1,697.31%3.21B | 1,443.41%3.2B | 1,377.96%3.21B | 1,483.91%3.35B | -17.20%178.61M | -5.02%207.39M | 1.77%217.26M | -0.26%211.72M |
| Total non current assets | 10.31%6.96B | 10.96%6.89B | 216.37%6.78B | 234.03%6.42B | 219.79%6.31B | 213.62%6.21B | 9.21%2.14B | 0.31%1.92B | 2.18%1.97B | 4.29%1.98B |
| Total assets | -0.54%18.38B | 0.12%17.56B | -2.83%17.48B | 9.75%18.71B | 1.04%18.48B | 2.69%17.54B | 11.75%17.99B | 7.17%17.05B | 21.41%18.29B | 16.96%17.08B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Short term loan | 0.35%841.4M | -6.12%838.13M | -15.38%831.94M | -18.51%832.1M | -22.37%838.48M | -9.81%892.79M | 20.80%983.19M | 14.38%1.02B | 19.48%1.08B | 1.95%989.93M |
| Notes payable and accounts payable | -1.81%567.29M | 13.89%548.68M | 29.66%541.85M | 1.29%508.42M | -24.73%577.75M | -28.43%481.77M | -4.12%417.9M | 9.54%501.93M | 83.97%767.54M | 44.29%673.15M |
| -Notes payable | 180.78%110.24M | 110.71%97.46M | 430.35%25.71M | -23.28%23.81M | -80.12%39.26M | -72.35%46.25M | -93.45%4.85M | -71.28%31.03M | 73.60%197.45M | 61.47%167.29M |
| -Accounts payable | -15.12%457.05M | 3.61%451.22M | 24.96%516.14M | 2.91%484.61M | -5.54%538.49M | -13.90%435.52M | 14.16%413.05M | 34.49%470.89M | 87.85%570.09M | 39.39%505.86M |
| Contract liabilities | 311.00%232.18M | -0.60%269.18M | 177.81%182.88M | 91.68%166.36M | -30.49%56.49M | 14.22%270.81M | -22.69%65.83M | -30.32%86.79M | -32.68%81.27M | -49.40%237.1M |
| Advance receipts | 50.44%18.9M | -57.93%2.38M | 194.57%8.43M | -32.53%6.45M | 5.03%12.57M | 58.12%5.67M | -81.65%2.86M | 215.55%9.56M | 44.78%11.96M | -61.97%3.58M |
| Salaries payable | 20.45%140.21M | 0.63%153.2M | 1.64%153.99M | 2.77%135.48M | -17.10%116.41M | 1.39%152.24M | -5.77%151.5M | 1.04%131.83M | 4.53%140.41M | 13.35%150.15M |
| Taxs payable | -20.06%206.28M | -73.40%24.75M | -49.44%136.6M | -55.90%88.41M | -18.29%258.04M | -46.21%93.05M | -9.42%270.18M | -15.15%200.48M | 48.84%315.81M | 60.41%172.98M |
| Other payable (including interest and dividends) | -48.23%216.73M | -43.81%233.05M | -79.62%238.76M | 162.71%1.42B | -37.00%418.65M | -30.35%414.74M | 179.78%1.17B | -50.06%540.12M | 99.18%664.5M | 120.06%595.47M |
| -Dividend payable | ---- | ---- | -100.00%31.5K | 111,799.40%1.1B | -99.58%31.5K | -99.59%31.5K | 11,731.81%693.81M | -99.87%981.3K | 7.31%7.45M | 9.93%7.63M |
| -Other payable | ---- | -43.80%233.05M | ---- | -40.48%320.89M | ---- | -29.45%414.71M | ---- | 67.68%539.13M | ---- | 122.96%587.84M |
| Non current liabilities due within one year | 7.46%44.33M | -5.87%40.29M | 43.91%40.44M | 53.98%42.44M | 38.63%41.25M | 26.92%42.81M | 0.32%28.1M | -7.47%27.56M | 0.71%29.76M | 15.46%33.73M |
| Other current liabilities | 93.36%8.34M | -25.20%14.91M | 17.22%6.25M | -45.58%4.23M | -36.37%4.31M | -26.22%19.94M | -15.55%5.33M | -44.55%7.77M | -10.45%6.78M | -50.51%27.02M |
| Total current liabilities | -2.08%2.28B | -10.50%2.12B | -30.85%2.14B | 26.74%3.2B | -24.99%2.32B | -17.66%2.37B | 36.86%3.1B | -14.93%2.53B | 42.94%3.1B | 14.86%2.88B |
| Current liabilities | ||||||||||
| Long term loan | -12.70%52.28M | -3.55%56.08M | 9.06%56.08M | 21.79%59.88M | 24.54%59.88M | 64.07%58.15M | 73.86%51.42M | 154.90%49.17M | --48.08M | --35.44M |
| Long term salaries pay | -0.48%52.68M | -0.20%53.17M | 55.46%52.84M | 52.97%53.2M | 53.02%52.93M | 52.04%53.28M | -1.58%33.99M | -0.47%34.78M | -0.46%34.59M | 2.20%35.04M |
| Estimate liabilities | --114.82K | --114.82K | ---- | ---- | ---- | ---- | ---- | ---- | --6.61M | --12M |
| Deferred tax liabilities | 14,682.71%61.51M | 15,979.77%52.98M | -99.24%217.51K | -90.82%2.06M | -98.57%416.07K | -98.90%329.45K | -48.80%28.8M | -54.45%22.49M | -56.81%29.03M | -50.86%30.02M |
| Long term deferred income | -1.37%25.86M | -1.58%26.26M | -4.32%26.01M | 19.50%26.21M | 42.43%26.22M | 51.03%26.68M | 59.04%27.18M | 24.31%21.94M | 10.88%18.41M | 3.87%17.67M |
| Lease liabilities | -10.13%130.01M | -17.42%127.66M | 17.55%130.48M | 25.22%136.43M | 26.34%144.66M | 44.07%154.58M | 14.37%111M | 10.38%108.95M | 10.51%114.5M | -1.39%107.29M |
| Other non current liabilities | -11.26%30.26M | -8.75%31.11M | -15.63%31.31M | -17.09%31.31M | -12.37%34.1M | -13.35%34.1M | -5.30%37.11M | -22.25%37.76M | -17.02%38.91M | -18.94%39.35M |
| Total non current liabilities | 10.84%352.71M | 6.19%347.37M | 2.57%296.93M | 12.36%309.1M | 9.67%318.21M | 18.17%327.11M | 5.78%289.49M | 2.44%275.09M | 7.83%290.14M | 2.63%276.81M |
| Total liabilities | -0.52%2.63B | -8.48%2.47B | -28.00%2.44B | 25.33%3.51B | -22.02%2.64B | -14.53%2.7B | 33.50%3.39B | -13.49%2.8B | 39.06%3.39B | 13.67%3.16B |
| Shareholders equity | ||||||||||
| Paid-in capital | 0.00%603.32M | 0.00%603.32M | 0.00%603.32M | 0.00%603.32M | 0.00%603.32M | 0.00%603.32M | 0.00%603.32M | 0.00%603.32M | 0.00%603.32M | 0.00%603.32M |
| Capital reserve funds | 0.01%1.1B | 0.02%1.09B | -0.04%1.09B | -0.05%1.09B | 0.02%1.09B | 0.01%1.09B | 0.07%1.1B | 0.07%1.1B | 0.08%1.09B | 0.09%1.09B |
| Surplus reserve funds | 10.26%2.08B | 10.26%2.08B | 17.70%1.89B | 17.70%1.89B | 17.70%1.89B | 17.70%1.89B | 18.68%1.61B | 18.68%1.61B | 18.68%1.61B | 18.68%1.61B |
| Retained profit | -2.05%11.37B | 0.17%10.62B | 1.93%10.79B | 6.14%10.95B | 5.80%11.61B | 6.11%10.61B | 7.44%10.59B | 14.74%10.32B | 22.23%10.97B | 21.82%10B |
| Other composite income | -9.53%61.71M | 71.85%132.18M | -28.98%90.68M | 80.66%85.46M | 15.91%68.21M | 0.41%76.92M | 27.31%127.68M | -45.28%47.3M | -32.18%58.85M | 2.95%76.6M |
| Shareholders equity without minority interests | -0.33%15.21B | 1.88%14.54B | 3.22%14.47B | 6.99%14.62B | 6.49%15.26B | 6.69%14.27B | 7.80%14.02B | 12.70%13.67B | 18.34%14.33B | 18.06%13.38B |
| Minority interests | -6.17%543.73M | -3.25%548.58M | -2.03%568.41M | -0.52%572.29M | 1.15%579.5M | 4.20%567.01M | 5.12%580.2M | 6.84%575.29M | 10.30%572.94M | 10.16%544.17M |
| Total shareholder equity | -0.54%15.76B | 1.68%15.09B | 3.01%15.04B | 6.68%15.2B | 6.28%15.84B | 6.60%14.84B | 7.69%14.6B | 12.45%14.24B | 18.01%14.91B | 17.73%13.92B |
| Total liabilityies and equity | -0.54%18.38B | 0.12%17.56B | -2.83%17.48B | 9.75%18.71B | 1.04%18.48B | 2.69%17.54B | 11.75%17.99B | 7.17%17.05B | 21.41%18.29B | 16.96%17.08B |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
| Auditor | -- | PwC China (Special General Partnership) | -- | -- | -- | PwC China (Special General Partnership) | -- | -- | -- | Huaxing Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Market Insights
Hot Topics Hot Topics
Middle East conflict spreads to the stock market! How should investors respond?
On May 19, Eastern Time, Trump issued a clear countdown: 'in two or three days—maybe Friday, Saturday, Sunday, or early next week'—the U.S.
牛牛課堂
Mar 4 17:09
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
牛牛課堂
Mar 18 18:18
Hormuz, Term Structure and USO: Navigating the Energy Storm